SUMMIT THERAPEUTICS PLC's ticker is SMMT and the CUSIP is 86627R102. A total of 3 filers reported holding SUMMIT THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,073,000 | +167.6% | 361,112 | +113.3% | 0.00% | – |
| Q1 2020 | $401,000 | +31.9% | 169,299 | -10.8% | 0.00% | – |
| Q4 2019 | $304,000 | +51.2% | 189,834 | +69.3% | 0.00% | – |
| Q3 2019 | $201,000 | +87.9% | 112,106 | +32.6% | 0.00% | – |
| Q2 2019 | $107,000 | -23.6% | 84,530 | +10.7% | 0.00% | – |
| Q1 2019 | $140,000 | +150.0% | 76,330 | +55.5% | 0.00% | – |
| Q4 2018 | $56,000 | -34.9% | 49,100 | +26.9% | 0.00% | – |
| Q3 2018 | $86,000 | -96.4% | 38,700 | -85.9% | 0.00% | -100.0% |
| Q2 2018 | $2,405,000 | +12.6% | 275,400 | +66.3% | 0.00% | -50.0% |
| Q1 2018 | $2,136,000 | +65.3% | 165,600 | +42.0% | 0.00% | +100.0% |
| Q4 2017 | $1,292,000 | +1.9% | 116,600 | +15.4% | 0.00% | 0.0% |
| Q3 2017 | $1,268,000 | +188.8% | 101,000 | +162.3% | 0.00% | 0.0% |
| Q2 2017 | $439,000 | +64.4% | 38,500 | +91.5% | 0.00% | – |
| Q1 2017 | $267,000 | – | 20,102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LANSDOWNE PARTNERS (UK) LLP | 2,667,350 | $7,922,000 | 0.33% |
| Polar Capital LLP | 4,500,000 | $13,365,000 | 0.12% |
| Inscription Capital, LLC | 17,000 | $50,000 | 0.03% |
| BBR PARTNERS, LLC | 50,000 | $149,000 | 0.02% |
| Checchi Capital Advisers, LLC | 20,000 | $59,000 | 0.01% |
| Cornerstone Investment Partners, LLC | 34,825 | $103,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 49,257 | $146,000 | 0.00% |
| Renaissance Technologies | 361,112 | $1,073,000 | 0.00% |
| HSBC HOLDINGS PLC | 150,975 | $448,000 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 11,000 | $35,000 | 0.00% |